Nevertheless, following the stimulation of CXCR4 with CXCL12 in MM cells, the activation of downstream signaling pathways remains obscure and the understanding of such signaling pathways represents an important molecular target for MM treatment [9]. The gene discussed is CXCR4; the disease is Miyoshi myopathy.